Literature DB >> 9696369

Current diagnostic and therapeutic management of CNS metastasis in childhood primitive neuroectodermal tumors and ependymomas.

W Scheurlen1, J Kühl.   

Abstract

Metastatic disease is a major problem in the management of the most frequent childhood brain tumors, in ependymoma and primitive neuroectodermal tumors (PNET). Today, contrast enhanced craniospinal MRI and careful analysis of craniospinal fluid are a prerequisite for correct staging of both tumors and imply therapeutic consequences. So far metastatic spread of medulloblastoma and some ependymomas is prevented by conventional chemotherapy and radiotherapy. However, some forms of diffuse metastatic dissemination in medulloblastoma are resistant to conventional therapeutic regimens and require new experimental strategies.

Entities:  

Mesh:

Year:  1998        PMID: 9696369     DOI: 10.1023/a:1005919900622

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  16 in total

1.  Spinal magnetic resonance imaging immediately after craniotomy for detection of metastatic disease.

Authors:  B A Kaufman; C J Moran; T S Park
Journal:  Pediatr Neurosurg       Date:  1995       Impact factor: 1.162

2.  Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).

Authors:  D M Tait; H Thornton-Jones; H J Bloom; J Lemerle; P Morris-Jones
Journal:  Eur J Cancer       Date:  1990-04       Impact factor: 9.162

3.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

Authors:  A E Evans; R D Jenkin; R Sposto; J A Ortega; C B Wilson; W Wara; I J Ertel; S Kramer; C H Chang; S L Leikin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

4.  Improvements in the radiotherapy of medulloblastoma, 1946-1975.

Authors:  T G Landberg; M L Lindgren; E K Cavallin-Ståhl; G O Svahn-Tapper; G Sundbärg; S Garwicz; J A Lagergren; V L Gunnesson; A E Brun; S E Cronqvist
Journal:  Cancer       Date:  1980-02-15       Impact factor: 6.860

5.  Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma.

Authors:  R J Packer; L N Sutton; J W Goldwein; G Perilongo; G Bunin; J Ryan; B H Cohen; G D'Angio; E D Kramer; R A Zimmerman
Journal:  J Neurosurg       Date:  1991-03       Impact factor: 5.115

6.  Systemic metastases from medulloblastoma: report of two cases and review of the literature.

Authors:  G M Kleinman; F H Hochberg; E P Richardson
Journal:  Cancer       Date:  1981-11-15       Impact factor: 6.860

7.  High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study.

Authors:  D H Mahoney; D Strother; B Camitta; T Bowen; T Ghim; T Pick; D Wall; L Yu; J J Shuster; H Friedman
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

8.  Complete myelographic evaluation of spinal metastases from medulloblastoma.

Authors:  R H Dorwart; W M Wara; D Norman; V A Levin
Journal:  Radiology       Date:  1981-05       Impact factor: 11.105

9.  Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.

Authors:  C C Bailey; A Gnekow; S Wellek; M Jones; C Round; J Brown; A Phillips; M K Neidhardt
Journal:  Med Pediatr Oncol       Date:  1995-09

10.  Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study.

Authors:  A E Evans; J R Anderson; I B Lefkowitz-Boudreaux; J L Finlay
Journal:  Med Pediatr Oncol       Date:  1996-07
View more
  2 in total

1.  Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms.

Authors:  Salvatore J Coniglio; Salvatore Zavarella; Marc H Symons
Journal:  Mol Cell Biol       Date:  2008-04-14       Impact factor: 4.272

Review 2.  [Differential infratentorial brain tumor diagnosis in children].

Authors:  M Warmuth-Metz; J Kühl; S Rutkowski; J Krauss; L Solymosi
Journal:  Radiologe       Date:  2003-11       Impact factor: 0.635

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.